Filing Details
- Accession Number:
- 0001104659-21-142473
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-22 16:05:53
- Reporting Period:
- 2021-11-19
- Accepted Time:
- 2021-11-22 16:05:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1736243 | Acurx Pharmaceuticals Inc. | ACXP | Pharmaceutical Preparations (2834) | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1127423 | J Robert Deluccia | C/O Acurx Pharmaceuticals, Inc., 259 Liberty Avenue Staten Island NY 10305 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-19 | 5,034 | $4.90 | 1,031,461 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 3,847 | Indirect | By spouse |
Footnotes
- The price reflects the average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $4.886 to $4.961 per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price.